Home NDC 73070-100 Insulin Aspart
Product NDC 73070-100
11-digit product format 730700100
Labeler code 73070
Product ID 73070-100_393af9a3-df9a-40b2-a5e6-bfa5434a2552
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name insulin aspart
Dosage form INJECTION, SOLUTION
Route INTRAVENOUS; SUBCUTANEOUS
Labeler Novo Nordisk Pharma, Inc.
Application BLA020986
Marketing category BLA
Marketing start 2001-08-27
Marketing end 2027-12-31
Substance INSULIN ASPART
Active strength 100 [iU]/mL
Pharmacologic classes Insulin Analog [EPC], Insulin [CS]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Additional Listing Data#
Finished product Yes
Brand name base Insulin Aspart Active Ingredients# Ingredient, Strength table Ingredient Strength INSULIN ASPART 100 [iU]/mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination D933668QVX Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 3 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 311040 Internal RxNorm lookup 1653196 Internal RxNorm lookup 1653202 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 73070-100-11 Insulin Aspart 10 mL in 1 VIAL, GLASS INJECTION, SOLUTION 10 5 73070-100-11 Insulin Aspart 1 in 1 CARTON INJECTION, SOLUTION 1 5
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 73070-100 INSULIN ASPART INJECTION, SOLUTION [NOVO NORDISK PHARMA, INC.] 5 Current NDC, Legacy NDC, 2 package rows 20230315_bee5b358-c863-420b-be73-ced2e920c499.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 7 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Insulin Aspart INSULIN ASPART REMEDYREPACK INC. b3d77cb0-cd47-441f-8f54-5329c655da9c 2026-01-14 Warnings, Adverse reactions Exact identifier application number: BLA020986 Insulin Aspart INSULIN ASPART A-S Medication Solutions c3e4c46e-5211-4f05-b7ab-1e9ad270876b 2024-09-11 Warnings, Adverse reactions Exact identifier application number: BLA020986 Insulin Aspart INSULIN ASPART A-S Medication Solutions bfd2b192-35e5-4773-ab73-802565b2ad78 2024-03-14 Warnings, Adverse reactions Exact identifier application number: BLA020986 NOVOLOG INSULIN ASPART A-S Medication Solutions 13891e5a-e57a-46e8-911c-2f680352b52b 2023-12-15 Warnings, Adverse reactions Exact identifier application number: BLA020986 NOVOLOG INSULIN ASPART A-S Medication Solutions e172b4f8-9b25-4019-8e09-afc10b2f30c9 2023-12-09 Warnings, Adverse reactions Exact identifier application number: BLA020986 Insulin Aspart INSULIN ASPART Novo Nordisk Pharma, Inc. bee5b358-c863-420b-be73-ced2e920c499 2023-02-28 Warnings, Adverse reactions Exact identifier application number: BLA020986 ndc (product): 73070-100 Insulin Diluting Medium for NovoLog WATER INJECTION Novo Nordisk 3a1e73a2-3009-40d0-876c-b4cb2be56fc5 2023-02-28 Warnings, Adverse reactions Exact identifier application number: BLA020986
Purple Book Biologic Products# BLA, Proprietary name, Proper name table BLA Proprietary name Proper name License type Status Latest source 020986 Novolog insulin aspart 351(a) Rx 2026-07-01
DailyMed RxNorm Mappings# RxCUI, RxNorm string, TTY table RxCUI RxNorm string TTY DailyMed SPL version 311040 insulin aspart 100 UNT/ML Injectable Solution PSN bfd2b192-35e5-4773-ab73-802565b2ad78 8 311040 insulin aspart, human 100 UNT/ML Injectable Solution SCD bfd2b192-35e5-4773-ab73-802565b2ad78 8 311040 insulin analog, aspart 100 UNT/ML Injectable Solution SY bfd2b192-35e5-4773-ab73-802565b2ad78 8 1653196 insulin aspart 100 UNT/ML in 3 ML Cartridge PSN bee5b358-c863-420b-be73-ced2e920c499 5 1653202 insulin aspart 100 UNT/ML in 3 ML Pen Injector PSN bee5b358-c863-420b-be73-ced2e920c499 5 311040 insulin aspart 100 UNT/ML Injectable Solution PSN bee5b358-c863-420b-be73-ced2e920c499 5 1653196 3 ML insulin aspart, human 100 UNT/ML Cartridge SCD bee5b358-c863-420b-be73-ced2e920c499 5 1653202 3 ML insulin aspart, human 100 UNT/ML Pen Injector SCD bee5b358-c863-420b-be73-ced2e920c499 5 311040 insulin aspart, human 100 UNT/ML Injectable Solution SCD bee5b358-c863-420b-be73-ced2e920c499 5 311040 insulin analog, aspart 100 UNT/ML Injectable Solution SY bee5b358-c863-420b-be73-ced2e920c499 5 1653196 insulin, aspart, human 100 UNT/ML per 3 ML Cartridge SY bee5b358-c863-420b-be73-ced2e920c499 5 1653202 insulin, aspart, human 100 UNT/ML per 3 ML Pen Injector SY bee5b358-c863-420b-be73-ced2e920c499 5
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 73070-100-11 73070010011 1 VIAL, GLASS in 1 CARTON (73070-100-11) / 10 mL in 1 VIAL, GLASS 2019-09-10 0000-00-00 No No Current